Table 1.
Days | Normal | OA | |||
---|---|---|---|---|---|
rAAV‐lacZ | rAAV‐hFGF‐2 | rAAV‐lacZ | rAAV‐hFGF‐2 | ||
Cells (104/sphere) | 1 | 0.77 (0.02) | 1.23 (0.02)* | 0.66 (0.02) | 1.11 (0.01)* |
26 | 0.35 (0.03) | 2.16 (0.01)* | 0.31 (0.02) | 1.83 (0.02)* | |
DNA contents | 1 | 0.41 (0.02) | 0.82 (0.01)* | 0.38 (0.01) | 0.75 (0.01)* |
26 | 0.25 (0.01) | 1.57 (0.02)* | 0.23 (0.01) | 1.46 (0.02)* | |
Proteoglycan production | 1 | 4.41 (0.01) | 4.44 (0.03) | 4.09 (0.01) | 4.10 (0.04) |
26 | 4.19 (0.02) | 4.21 (0.03) | 4.00 (0.02) | 4.01 (0.03) | |
Type‐II collagen production | 1 | 0.14 (0.01) | 0.15 (0.01) | 0.08 (0.01) | 0.09 (0.01) |
26 | 0.10 (0.01) | 0.10 (0.01) | 0.06 (0.01) | 0.06 (0.01) |
*Significant compared with rAAV‐lacZ.